Edward S. M. Bahnson

Dr. Bahnson holds a B.Sc. in Biochemistry from the University of Uruguay. He received his Ph.D. in Biomedical Sciences working with Drs. Nicola Brasch (Kent State University), June Yun (NEOMED), and Donald Jacobsen (Cleveland Clinic). His dissertation, entitled “Vascular Biochemistry of Vitamin B12,” explored the non-coenzyme effects of B12 derivatives on vascular redox homeostasis. For his postdoctoral training, he joined the Simpson Querrey Institute and the Division of Vascular Surgery at Northwestern University. He focused on the prevention of restenosis after vascular interventions using local and targeted redox interventions, and the development of targeted nanostructures for the vasculature.

Dr. Edward Moreira Bahnson is an Assistant Professor at the Dept. of Surgery and the Center for Nanotechnology in Drug Delivery at UNC Chapel Hill. Dr. Bahnson’s research program focuses on the study of arterial disease. The Bahnson Research Group aims to understand how redox dysfunction affects arterial disease progression with the goal of developing redox-based targeted therapies for the vasculature. Dr. Bahnson has been funded by the AHA and has received NIH funding to study the development of targeted nanoparticle systems to deliver antioxidants to sites of atherosclerosis. He serves in the leadership of the Society for Redox Biology and Medicine.